Abstract
Background
Colonic cancer is the most common cancer of the gastrointestinal tract. The aim of this study was to determine mortality rates following colonic cancer resection and the effect of hospital caseload on in‐hospital mortality in Germany.
Methods
Patients admitted with a diagnosis of colonic cancer undergoing colonic resection from 2012 to 2015 were identified from a nationwide registry using procedure codes. The outcome measure was in‐hospital mortality. Hospitals were ranked according to their caseload for colonic cancer resection, and patients were categorized into five subgroups on the basis of hospital volume.
Results
Some 129 196 colonic cancer resections were reviewed. The overall in‐house mortality rate was 5·8 per cent, ranging from 6·9 per cent (1775 of 25 657 patients) in very low‐volume hospitals to 4·8 per cent (1239 of 25 825) in very high‐volume centres (P < 0·001). In multivariable logistic regression analysis the risk‐adjusted odds ratio for in‐house mortality was 0·75 (95 per cent c.i. 0·66 to 0·84) in very high‐volume hospitals performing a mean of 85·0 interventions per year, compared with that in very low‐volume hospitals performing a mean of only 12·7 interventions annually, after adjustment for sex, age, co‐morbidity, emergency procedures, prolonged mechanical ventilation and transfusion.
Conclusion
In Germany, patients undergoing colonic cancer resections in high‐volume hospitals had with improved outcomes compared with patients treated in low‐volume hospitals.
Abstract
Antecedentes
El cáncer de colon es el cáncer más frecuente del tracto digestivo. El objetivo de este estudio fue determinar las tasas de mortalidad tras resección de cáncer de colon y el efecto del volumen de casos del hospital sobre la mortalidad intrahospitalaria en Alemania.
Métodos
Los pacientes ingresados con el diagnóstico de cáncer de colon sometidos a resección colónica entre 2012 y 2015 se identificaron a partir de un registro nacional utilizando los códigos de los procedimientos. La medida de resultado fue la mortalidad intrahospitalaria. Los hospitales se clasificaron de acuerdo con su número de casos de resecciones de cáncer de colon y los pacientes fueron categorizados en 5 diferentes subgrupos en la base del volumen del hospital.
Resultados
Se revisaron 129.196 resecciones de cáncer de colon. La tasa de mortalidad fue de 5,75%, variando desde 6,92% (n = 1.775) en hospitales de bajo volumen hasta 4,80% (n = 1.239) en centros con alto volumen, con una diferencia significativa entre los escenarios de bajo y alto volumen (P < 0,001). El análisis de regresión logística multivariable puso de manifiesto que la razón de oportunidades (odds ratio, OR) ajustada al riesgo de la mortalidad intrahospitalaria fue de 0,75 (i.c. del 95% 0,66‐0,84) en hospitales con volumen muy alto que realizaban más de 85,0 intervenciones/año, en comparación con hospitales de volumen muy bajo que realizaban menos de 13 intervenciones/año, tras ajustar por sexo, edad, comorbilidad, procedimiento urgente, ventilación mecánica prolongada y transfusiones.
Conclusión
En Alemania, los pacientes sometidos a resección de cáncer de colon en hospitales de alto volumen tienen mejores resultados en comparación con los pacientes tratados en centros de bajo volumen.
Abstract
In Germany, perioperative mortality for colonic cancer resection at the national level is high. Patients undergoing resection of colonic cancer in high‐volume hospitals have improved outcomes compared with those treated in low‐volume hospitals.
Mortality rate, hospital volume and CRC resections
Introduction
Colorectal cancer is the most common malignancy of the gastrointestinal tract, affecting more than one million patients per year worldwide and accounting for more than 500 000 deaths1. Over the past two decades the introduction of membrane anatomy surgery with respect to embryological planes has led to improved long‐term survival rates but also increased perioperative morbidity and mortality2, 3, 4, 5, 6, 7. Although large multicentre studies have demonstrated low complication rates and a low 30‐day mortality rate after colorectal cancer resection8, these results could be biased by hospital volume. In addition, population‐based analyses suggest mortality rates of up to 6 per cent9, 10, 11, leading to an increased interest in quality assurance indicators in medicine and surgery.
A Cochrane review12 including nearly one million patients suggested that surgeon experience and hospital volume have a significant impact on short‐ and long‐term survival after colonic cancer surgery. Even though the German Cancer Society currently certifies centres with a minimum caseload of 50 colorectal cancer resections per year (30 colonic and 20 rectal), no official guidelines have been issued regarding the minimum number of patients with colonic cancer that should be treated annually per hospital, and around 50 per cent of the patients are still treated in non‐board‐certified hospitals.
The primary aim of this study was to analyse in‐house mortality following colonic cancer surgery in Germany according to hospital volume.
Methods
Data of individual inpatients treated from January 2012 to December 2015 were obtained from the nationwide German diagnosis‐related group (DRG) statistics13. Inclusion criteria were a DRG code for colonic cancer (C18 as main diagnosis) and a colonic resection performed in a German hospital.
Procedure codes for colonic resection ranged from colectomy to resection of a colonic segment, with the exclusion of appendicectomy. Procedures were considered hierarchically, whereas more extensive resections were defined as the principal intervention to avoid double‐counting.
DRG data were accessed by controlled remote data analysis via the Research Data Centre of the Federal Statistical Office, in accordance with German legal data protection regulations. Data included secondary diagnoses, sex, patient age and duration of hospital stay. For case identification and data analysis, the German adaptation of ICD‐10 (ICD‐10‐GM) codes and German procedure codes (OPS codes) were used (versions 2012–2015; Table S1, supporting information)14. Analysis was restricted to patients with complete data records. When there were duplicate data, one data set was chosen at random and included for further analysis.
Hospitals were ranked according to their caseload for colonic cancer resections (continuous variable) and patients were categorized into five subgroups on the basis of hospital volume.
Outcome measure
The main outcome of this study was in‐hospital mortality, defined as death while an inpatient irrespective of the actual length of hospital stay (LOS).
Co‐morbidities
To account for differences in the co‐morbidity profile of patients between hospital volume quintiles, the co‐morbidity score was determined for each patient as proposed by Stausberg and Hagn15, based on ICD‐10 groups. Data on other potential confounders, such as sex, age or emergency procedures, were considered similarly and included in the analysis.
Statistical analysis
In a first step, raw data were screened for missing values and checked for plausibility. The continuous variable age was recoded as a categorical dummy variable with three age categories (54 years or less, 55–74 years and 75 years or more). The cut‐offs were chosen based on pre‐existing epidemiological data, thereby assuring similar group sizes for the second and third age groups and confining patients with a presumably higher incidence of genetic aberration leading to early‐onset colonic cancer to one age group.
Patient characteristics were analysed descriptively for each year and according to hospital volume quintiles. Temporal trends and trends across volume categories were accessed by means of a non‐parametric test for trend, described elsewhere16.
Second, univariable odds ratios (ORs) between the main dependent variable (in‐house mortality) and the main independent variable (hospital volume quintile) were determined using Pearson's χ2 test or univariable logistic regression analysis, as appropriate. In addition, crude ORs between the secondary independent variables (listed below), the main independent variable and the outcome of interest were calculated to identify potential confounders. The possibility of important effect modification was assessed using the Mantel–Haenszel method, adjusting for each potential confounder. Correlation between each pair of variables was determined to detect multicollinearity.
The effect of hospital volume on in‐house mortality was evaluated by using a multivariable logistic regression model that included hospital volume as a random effect to account for clustering of patients in different institutions. The multivariable model was adjusted for known confounding effects such as sex, age, emergency procedures, co‐morbidity, mechanical ventilation for 48 h or more, and blood transfusion of 6 units or more. The model was also fitted with the number of patients per hospital as a continuous variable and with hospital volume quintile as a linear variable. Likelihood ratio tests were used to assess the model's fit and to evaluate the presence of linear trends.
The accuracy of the random‐effects estimators of the multivariable regression models was checked by refitting the models for different numbers of points and subsequent comparison of the values of the estimators. A maximum relative difference of 10−4 or less between the different quadrature points was considered acceptable.
Where appropriate, 95 per cent confidence intervals and P values were calculated. P < 0·050 was considered significant. All calculations were conducted using Stata® version 14.2 (StataCorp, College Station, Texas, USA).
Results
A total of 129 450 patients with a diagnosis of colonic cancer (ICD C18) who had colonic resection (relevant subgroups of OPS codes 545 and 5484) between 1 January 2012 and 31 December 2015 were identified from the nationwide DRG database of the German Federal Statistical Office. Missing data or duplicates occurred in 0·2 per cent (254 patients), leaving 129 196 patients for further analysis (Fig. 1).
The mean annual number of cases/hospital was 30·1 (Table 1). Some 47·8 per cent of the patients were women and the mean age was 71·7 years. Emergency procedures accounted for 29·6 per cent of the cases. The most frequent surgical procedure was right‐sided hemicolectomy, followed by left‐sided resections.
Table 1.
No. of patients | Mortality rate (%) | P † | |
---|---|---|---|
Total no. of patients | 129 196 | 5·8 | |
Hospital volume | |||
Resections per hospital 2012–2015* | 120·5(91·9) | ||
Annual resections per hospital | 30·1 | ||
Age (years)* | 71·7(11·8) | ||
Age group (years) | < 0·001 | ||
≤ 54 | 11 733 | 1·2 | |
55–74 | 57 948 | 3·2 | |
≥ 75 | 59 515 | 9·2 | |
Sex | < 0·001 | ||
F | 61 800 | 5·2 | |
M | 67 396 | 6·3 | |
Type of resection | < 0·001 | ||
Extended (total/subtotal) | 15 560 | 7·6 | |
Right‐sided | 62 278 | 5·6 | |
Transverse | 4070 | 6·6 | |
Left‐sided | 43 925 | 5·0 | |
Other | 3363 | 8·2 | |
Emergency procedure | 38 181 | 8·9 | |
Co‐morbidity score* | 100·6(2·4) | ||
Duration of hospital stay (days)* | 19·6(13·5) |
*Values are mean(s.d.). †χ2 test.
Overall, the nationwide in‐house mortality for colonic cancer surgery was 5·8 per cent. The mortality rate was higher in the elderly and in men. Extended colonic resection carried a 7·6 per cent risk of in‐hospital death, whereas the mortality rate was less for right‐ and left‐sided colectomies (5·6 and 5·0 per cent respectively) (Table 1).
No significant differences were reported in the total number of patients or in mean age during the study period. However, mean LOS decreased over time: 20·4 days in 2012 versus 18·8 days in 2015 (P < 0·001, data not shown).
Hospital volumes and mortality
Hospitals were grouped into five case‐load quintiles with approximately the same absolute number of patients (258 392 per quintile, with a maximum absolute difference of 0·3 per cent between volume groups). Some 506 of the 1072 hospitals were in the very low quintile, and 76 hospitals were in the very high‐volume category (Table 2 and Fig. 2 a).
Table 2.
Hospital volume quintiles (no. of procedures) | ||||||
---|---|---|---|---|---|---|
Very low (1–97) | Low (98–143) | Medium (144–191) | High (192–259) | Very high (260–1085) | P ‡ | |
No. of hospitals | 506 | 217 | 156 | 117 | 76 | |
Total no. of patients | 25 657 | 25 828 | 26 091 | 25 795 | 25 825 | |
Volume per hospital, 2012–2015* | 50·7(27·5) | 119·0(13·3) | 167·3(14·4) | 220·5(19·7) | 339·8(110·7) | < 0·001 |
Annual volume per hospital* | 12·7 | 29·8 | 41·8 | 55·1 | 85·0 | < 0·001 |
Mortality (%) | 1775 (6·9) | 1657 (6·4) | 1488 (5·7) | 1273 (4·9) | 1239 (4·8) | < 0·001 |
Age (years)* | 73·0(11·5) | 71·9(11·6) | 71·7(11·7) | 71·0(11·7) | 70·7(12·2) | < 0·001§ |
Women | 12 676 (49·4) | 12 432 (48·1) | 12 418 (47·6) | 12 026 (46·6) | 12 248 (47·4) | < 0·001 |
Type of resection† | ||||||
Extended (total/subtotal) | 2829 (9·7) | 2933 (9·5) | 3302 (7·3) | 3082 (6·4) | 3414 (6·0) | < 0·001 |
Right‐sided | 12 649 (6·5) | 12 507 (6·4) | 12 711 (5·6) | 12 161 (4·7) | 12 250 (4·9) | < 0·001 |
Transverse | 865 (8·5) | 843 (8·2) | 826 (5·2) | 805 (5·5) | 731 (5·3) | 0·005 |
Left‐sided | 8522 (6·2) | 8823 (5·2) | 8563 (5·2) | 9181 (4·4) | 8836 (4·0) | < 0·001 |
Emergency procedure† | 7874 (9·9) | 8080 (9·3) | 7609 (8·8) | 7352 (8·3) | 7266 (8·0) | < 0·001 |
Co‐morbidity score* | 100·7(2·4) | 100·7(2·4) | 100·6(2·4) | 100·5(2·3) | 100·5(2·3) | n.a. |
Duration of hospital stay (days)* | 20·3(12·8) | 20·2(13·4) | 19·9(13·8) | 19·0(13·4) | 18·7(13·9) | < 0·001§ |
Ventilation for > 48 h† | 1542 (39·8) | 1570 (39·6) | 1401 (38·7) | 1244 (40·5) | 1367 (37·0) | < 0·001 |
Transfusion ≥ 6 units† | 258 (17·1) | 281 (16·7) | 189 (18·5) | 225 (21·8) | 259 (18·9) | < 0·001 |
Values in parentheses are percentages of number of patients in that quintile, unless indicated otherwise; *values are mean(s.d.); †values in parentheses are mortality rates. n.a., Not applicable. ‡χ2 test, except §Wilcoxon test for trend.
A mean of 12·7 patients were treated annually in very low‐volume hospitals, whereas very high‐volume hospitals performed 85·0 colonic resections per year. The mean age of the patients varied according to hospital quintile: 73·0 years in the very low‐volume versus 70·7 years in the very high‐volume category (P < 0·001).
There was a significant inverse association between hospital volume and mortality during hospital stay. Crude in‐house mortality rates ranged from 6·9 per cent (1775 of 25 657 patients) in hospitals in the lowest volume category to 4·8 per cent (1239 of 25 825) in the highest‐volume centres (P < 0·001) (Table 2).
After stratification for cancer localization, low‐volume hospitals had a significantly higher mortality rate than high‐volume hospitals (Table 2).
Mean LOS was similar (20·3 days in very low‐volume hospitals versus 18·7 days in very high‐volume hospitals; P < 0·001), whereas the percentage of emergency procedures was significantly lower in high‐volume centres (P < 0·001).
Univariable analysis documented that sex, age category, co‐morbidity, emergency procedures, prolonged mechanical ventilation and blood transfusion of 6 units or more were significantly associated with in‐house mortality. Mortality increased with fewer patients treated per hospital (Table 3).
Table 3.
Crude odds ratio | P | |
---|---|---|
Case‐load quintile | ||
I | 1·00 (reference) | |
II | 0·92 (0·86, 0·99) | 0·022 |
III | 0·81 (0·76, 0·88) | < 0·001 |
IV | 0·70 (0·65, 0·75) | < 0·001 |
V | 0·68 (0·63, 0·73) | < 0·001 |
Sex | ||
F | 1·00 (reference) | |
M | 1·24 (1·18, 1·30) | < 0·001 |
Age group (years) | ||
≤ 54 | 1·00 (reference) | |
55–74 | 2·79 (2·34, 3·33) | < 0·001 |
≥ 75 | 8·70 (7·33, 10·33) | < 0·001 |
Co‐morbidity score | 1·32 (1·31, 1·34) | < 0·001 |
Emergency procedure | ||
No | 1·00 (reference) | |
Yes | 2·10 (2·00, 2·20) | < 0·001 |
Ventilation for ≥ 48 h | ||
No | 1·00 (reference) | |
Yes | 16·25 (15·36, 17·18) | < 0·001 |
Transfusion ≥ 6 units | ||
No | 1·00 (reference) | |
Yes | 3·80 (3·30, 4·40) | < 0·001 |
Values in parentheses are 95 per cent confidence intervals.
In multivariable regression, accounting for patient clustering within institutions and for the effect of the confounding variables, a highly significant decreasing trend was found for in‐house death following colonic cancer surgery across hospital volume categories. The OR for death was 25 per cent lower in the highest volume centres, 21 per cent in the fourth highest, and 12 per cent lower in the third highest volume category compared with the baseline rate in the lowest volume hospitals. In the multivariable model, the observed decrease in the OR for in‐hospital death between the two lowest volume categories was not significant (Table 4). A model with volume category fitted as a linear predictor variable for in‐hospital death performed equally well (OR 0·93, 95 per cent c.i. 0·90 to 0·95; P < 0·001). The number of patients was also determined as a continuous variable. This regression model displayed a highly significant linear trend between the number of patients treated and the risk of inpatient death following colonic cancer surgery (OR per individual patient: 0·999, 0·9987 to 0·9994; P < 0·001).
Table 4.
Adjusted odds ratio | P | |
---|---|---|
Case‐load quintile | ||
I | 1·00 (reference) | |
II | 0·94 (0·86, 1·04) | 0·242 |
III | 0·88 (0·79, 0·98) | 0·015 |
IV | 0·79 (0·71, 0·89) | < 0·001 |
V | 0·75 (0·66, 0·84) | < 0·001 |
Sex | ||
F | 1·00 (reference) | |
M | 1·18 (1·12, 1·25) | < 0·001 |
Age group (years) | ||
≤ 54 | 1·00 (reference) | |
55–74 | 2·34 (1·95, 32·81) | < 0·001 |
≥ 75 | 6·81 (5·70, 8·13) | < 0·001 |
Co‐morbidity score | 1·18 (1·17, 1·19) | < 0·001 |
Emergency procedure | ||
No | 1·00 (reference) | |
Yes | 1·71 (1·62, 1·80) | < 0·001 |
Ventilation for ≥ 48 h | ||
No | 1·00 (reference) | |
Yes | 12·08 (11·34, 12·86) | < 0·001 |
Transfusion ≥ 6 units | ||
No | 1·00 (reference) | |
Yes | 1·64 (1·37, 1·95) | < 0·001 |
Values in parentheses are 95 per cent confidence intervals.
Discussion
In this nationwide population‐based study, overall in‐house mortality following colonic surgery showed a significant correlation with hospital volume. This correlation was documented overall, as well as for different surgical approaches or emergency surgery. In an adjusted model, in‐house mortality was 25 per cent higher in very low‐volume hospitals compared with very high‐volume hospitals.
A major strength of this study is the completeness of the data, as every inpatient treated surgically for colonic cancer in Germany was included. The present findings correlate well with the results of a previous analysis17 from the Berlin Cancer Registry that focused on colonic cancer.
Although hospitals are monitored closely by the German statutory assurances' medical services, overreporting or underreporting cannot be excluded completely. In addition, co‐morbidities were included in the regression model using a score validated for German DRG data. This validated score outperforms other commonly used scores15. Unfortunately, it was not possible to distinguish between a de novo co‐morbid condition, which appeared during the hospital stay, or pre‐existing co‐morbidities.
Finally, no data on 30‐ or 90‐day mortality rates after colonic cancer resection could be provided, and the federal DRG data did not contain information about tumour stage or metastasis.
The results of in‐house or 30‐day mortality are in line with those from previous population‐based studies in this field9, 10, 11. Previous research12 has also documented that high‐volume hospitals, surgeons with a specialization in colorectal surgery, and surgeon caseload are associated with better short‐ and long‐term outcomes.
Currently the German Cancer Society certifies oncological care centres and, for colonic cancer, centres have to fulfil several criteria, amongst which is an annual caseload of more than 30 patients with colonic cancer. In 2015, 273 centres were board‐certified and performed a total of 15 627 colonic cancer resections. This accounts for approximately 50 per cent of all colonic and rectal cancer resections in Germany. The remaining patients were treated in uncertified centres. The reported18 overall 30‐day mortality rate following colorectal surgery in board‐certified centres was 2·4 per cent. However, these results cannot be compared directly with those found in the present study as emergency cases were included here.
Disclosure
The authors declare no conflict of interest.
Supporting information
Funding information
No funding
References
- 1. Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RGS, Barzi A et al. Colorectal cancer statistics, 2017. CA Cancer J Clin 2017; 67: 177–193. [DOI] [PubMed] [Google Scholar]
- 2. André T, Boni C, Mounedji‐Boudiaf L, Navarro M, Tabernero J, Hickish T et al.; Multicenter International Study of Oxaliplatin/5‐Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) Investigators. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004; 350: 2343–2351. [DOI] [PubMed] [Google Scholar]
- 3. André T, Boni C, Navarro M, Tabernero J, Hickish T, Topham C et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 2009; 27: 3109–3116. [DOI] [PubMed] [Google Scholar]
- 4. André T, de Gramont A, Vernerey D, Chibaudel B, Bonnetain F, Tijeras‐Raballand A et al. Adjuvant fluorouracil, leucovorin, and oxaliplatin in stage II to III colon cancer: updated 10‐year survival and outcomes according to BRAF mutation and mismatch repair status of the MOSAIC study. J Clin Oncol 2015; 33: 4176–4187. [DOI] [PubMed] [Google Scholar]
- 5. Hohenberger W, Weber K, Matzel K, Papadopoulos T, Merkel S. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation – technical notes and outcome. Colorectal Dis 2009; 11: 354–364. [DOI] [PubMed] [Google Scholar]
- 6. Bertelsen CA, Neuenschwander AU, Jansen JE, Wilhelmsen M, Kirkegaard‐Klitbo A, Tenma JR et al.; Danish Colorectal Cancer Group. Disease‐free survival after complete mesocolic excision compared with conventional colon cancer surgery: a retrospective, population‐based study. Lancet Oncol 2015; 16: 161–168. [DOI] [PubMed] [Google Scholar]
- 7. Bertelsen CA, Neuenschwander AU, Jansen JE, Kirkegaard‐Klitbo A, Tenma JR, Wilhelmsen M et al.; Copenhagen Complete Mesocolic Excision Study (COMES); Danish Colorectal Cancer Group (DCCG). Short‐term outcomes after complete mesocolic excision compared with ‘conventional’ colonic cancer surgery. Br J Surg 2016; 103: 581–589. [DOI] [PubMed] [Google Scholar]
- 8. Colon Cancer Laparoscopic or Open Resection Study Group , Buunen M, Veldkamp R, Hop WC, Kuhry E, Jeekel J et al. Survival after laparoscopic surgery versus open surgery for colon cancer: long‐term outcome of a randomised clinical trial. Lancet Oncol 2009; 10: 44–52. [DOI] [PubMed] [Google Scholar]
- 9. Panis Y, Maggiori L, Caranhac G, Bretagnol F, Vicaut E. Mortality after colorectal cancer surgery: a French survey of more than 84 000 patients. Ann Surg 2011; 254: 738–743. [DOI] [PubMed] [Google Scholar]
- 10. Mamidanna R, Burns EM, Bottle A, Aylin P, Stonell C, Hanna GB et al. Reduced risk of medical morbidity and mortality in patients selected for laparoscopic colorectal resection in England: a population‐based study. Arch Surg 2012; 147: 219–227. [DOI] [PubMed] [Google Scholar]
- 11. de Vries S, Jeffe DB, Davidson NO, Deshpande AD, Schootman M. Postoperative 30‐day mortality in patients undergoing surgery for colorectal cancer: development of a prognostic model using administrative claims data. Cancer Causes Control 2014; 25: 1503–1512. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Archampong D, Borowski D, Wille‐Jørgensen P, Iversen LH. Workload and surgeon's specialty for outcome after colorectal cancer surgery. Cochrane Database Syst Rev 2012; (14)CD005391. [DOI] [PubMed]
- 13. Research Data Centres of the Federal Statistical Office and the Statistical Offices of the Länder . Data Supply Diagnosis‐Related Group Statistics (2012–15). http://www.forschungsdatenzentrum.de/en/database/drg/index.asp [accessed 26 February 2018]. [Google Scholar]
- 14.Deutsches Institut für Medizinische Dokumentation und Information (DIMDI). Klassifikationen, Terminologien und Standards im Gesundheitswesen https://www.dimdi.de/dynamic/de/klassifikationen/ [accessed 10 April 2019].
- 15. Stausberg J, Hagn S. New morbidity and comorbidity scores based on the structure of the ICD‐10. PLoS One 2015; 10: e0143365. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Cuzick J. A Wilcoxon‐type test for trend. Stat Med 1985; 4: 87–90. [DOI] [PubMed] [Google Scholar]
- 17. Schad F, Merkle A, Darmkrebs in Berlin Schicke B. – Auswertung von 10·486 Fällen der regionalen Tumorzentren Berlins aus dem Zeitraum 2000–2008. 19th Informationstagung Tumordokumentation der Klinischen und Epidemiologischen Krebsregister, 29–31 March 2011, Bayreuth.
- 18.Deutsche Krebsgesellschaft (DKG). Jahresberichte https://www.krebsgesellschaft.de/jahresberichte.html [accessed 10 April 2019].
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.